Fluorodeoxyglucose-positron emission tomography staging can replace bone marrow biopsy in Hodgkin's lymphoma. Results from Brazilian Hodgkin's Lymphoma Study Group

OBJECTIVE: To investigate, in a large prospective multicenter study, whether 2-[18F]-fluoro-2-deoxy-d-glucose-positron emission tomography is sufficiently accurate to identify clinically important bone marrow involvement by Hodgkin's lymphoma to replace routine bone marrow biopsy in a developin...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Hematol Transfus Cell Ther
Main Authors: Cerci, Juliano Júlio, Bogoni, Mateos, Buccheri, Valeria, Etchebehere, Elba Cristina Sá de Camargo, Silveira, Talita Maira Bueno da, Baiocchi, Otavio, Neto, Carlos de Araujo Cunha Pereira, Sapienza, Marcelo Tatit, Marin, Jose Flavio Gomes, Meneghetti, José Cláudio, Novis, Yana, Souza, Carmino Antonio de, Chiattone, Carlos, Torresan, Marcia, Ramos, Celso Dario
פורמט: Artigo
שפה:Inglês
יצא לאור: Sociedade Brasileira de Hematologia e Hemoterapia 2018
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6098181/
https://ncbi.nlm.nih.gov/pubmed/30128433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.htct.2018.03.002
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים